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ABSTRACT The neuron-restrictive silencer factor
(NRSF) represses transcription of several neuronal genes in
nonneuronal cells by binding to a 21-bp element called the
neuron-restrictive silencer element (NRSE). We have per-
formed data base searches with a composite NRSE to identify
additional candidate NRSF target genes. Twenty-two more
genes, 17 of which are expressed mainly in neurons, were
found to contain NRSE-like sequences. Many of these putative
NRSEs bound NRSF in vitro and repressed transcription in
vivo. Most of the neuronal genes identified contribute to the
basic structural or functional properties of neurons. However,
two neuronal transcription factor genes contain NRSEs,
suggesting that NRSF may repress neuronal differentiation
both directly and indirectly. Functional NRSEs were also
found in several nonneuronal genes, implying that NRSF may
play a broader role than originally anticipated.
Transcriptional regulation of gene expression is an important
mechanism in the development of neurons. Genes encoding
transcriptional regulatory proteins have been revealed by
many of the mutations affecting neuronal development in
organisms such as Drosophila and Caenorhabditis elegans (1, 2).
Overexpression of transcription factors inXenopus oocytes and
targeted mutagenesis of transcription factor genes in mice have
also shown the importance of transcriptional regulation during
vertebrate neuronal determination and differentiation (3-7).
In parallel to these genetic studies, molecular analyses have
identified transcription factors common to subsets of neurons
that may be important for establishing and maintaining a
particular neuronal phenotype (8-12).
To understand the biological role of a transcription factor,
it is important to determine the complement of genes it
regulates. For example, in pituitary cells, Pit-1 is essential for
proper pituitary development and is known to activate its own
gene as well as other pituitary-specific genes, such as prolactin
(8, 13). Similarly, a target for mec-3 and unc-86, two proteins
necessary for neurogenesis in C. elegans, is the mec-3 gene
itself (1, 14) as well as the mec-7 tubulin gene (15). For the
most part, however, target genes for other transcriptional
regulators implicated in neural development have not yet
been identified.
While most transcription factors thought to be involved in
neurogenesis act positively, the importance of negative regu-
lation in this process is becoming increasingly clear (16, 17).
One of the first negative-acting transcriptional regulators to be
implicated in vertebrate neuronal development is the neuron-
restrictive silencer factor (NRSF; also known as REST). NRSF
was originally defined as a silencer-binding protein for the
neuron-specific gene, SCGlO (18). NRSF also negatively reg-
ulates the type II sodium channel and synapsin I genes (19, 20).
NRSF is a zinc-finger transcription factor (21, 22) that binds to
a conserved element known as the neuron-restrictive silencer
element (NRSE) or repressor element-1 (18, 19). In contrast
to most positive regulators of neuronal genes, NRSF activity,
protein, and mRNA are not present in the majority of neuronal
cells but are instead found in most nonneuronal cell types (18,
19, 21, 22). Thus, NRSF appears to prevent expression of
certain neuronal genes in nonneuronal cells. In addition,
NRSF mRNA is expressed in undifferentiated neural precur-
sors (21, 22), suggesting that it may prevent precocious ex-
pression of the neuronal phenotype during neurogenesis.
A further understanding of NRSF function would be aided
by the identification of additional target genes. In this report,
we provide evidence that there are many neuronal genes that
contain NRSE-like sequences and that these sequences are
likely to act as NRSF-mediated silencer elements. Further-
more, these genes are involved in a wide range of neuronal
functions and include two transcription factors that may be
positive regulators of neuronal differentiation. Potential
NRSEs are also found in some nonneuronal genes, suggesting
that NRSF may regulate nonneuronal as well as neuronal
genes.
MATERIALS AND METHODS
DNA Data Base Searching. A composite NRSE was derived
from the NRSE sequences in the rat SCG10, rat type II sodium
channel, human synapsin I, and rat BDNF genes, all of which
have been shown to bind NRSF (22). A single nucleotide was
assigned to a given position if it occurred in at least three of
these four NRSE sequences, and more variable positions were
assigned an N. This sequence (TTCAGCACCNCGGA-
CAGNGCC) was used to search the GenBank DNA sequence
data base using the FASTA search program (23). The param-
eters used were: word size, 1 and 3; gap penalty, 12.0; and gap
extension penalty, 4.0. Sequences in GenBank are divided
into four different sections (rodents, primates, other mam-
mals, and other vertebrates), and each of these sections was
searched separately. The top 300 sequences were retrieved
from each search. Alignments were not considered further if
they contained gaps or two mismatches at the adjacent G
residues known to be necessary for NRSF binding (18).
Sequences were also removed from consideration if they
were located in genes of unknown expression pattern or
function (such as sequence tagged sites or pseudogenes). In
determining the number of distinct genes identified, homol-
ogous genes from different species were counted as one.
Similarly, members of closely related multigene families,
such as olfactory receptors and cytochrome P450s, were
counted as single genes, even if several members contained
potential NRSEs.
Electrophoretic Mobility-Shift Assays (EMSAs) and Tran-
sient Transfections. EMSAs were performed using native
Abbreviations: NRSF, neuron-restrictive silencer factor; NRSE, neu-
ron-restrictive silencer element; EMSA, electrophoretic mobility-shift
assay.
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NRSF and in vitro-translated, truncated human NRSF (AHi)
essentially as described (18, 22), except that, in the experiments
shown, Klenow-labeled, double-stranded oligonucleotides
were used as probes. Oligonucleotides were inserted into the
Hindlll site of the SCG1O promoter reporter construct, CAT3
(26). Cell culture, transient transfections of 1OT1/2 cells, and
chloramphenicol acetyltransferase assays were performed as
described (18, 22).
NRSE Oligonucleotides. Oligonucleotides were generated
from the NRSE-like sequences listed in Table 1. In addition to
the core NRSE-like sequence, the oligos contained an addi-
tional 5 bp from the endogenous gene on either side and
HindlIl-compatible ends to facilitate subcloning. Precise se-
quences are available on request.
Proc. Natl. Acad. Sci. USA 93 (1996)
RESULTS
Potential NRSF Target Genes. A search of the GenBank
DNA sequence data base using a 21-bp composite NRSE (see
Materials and Methods) revealed a large set of genes containing
sequences with substantial similarity to the composite. This set
included 25 distinct genes containing presumptive NRSEs with
two or fewer mismatches to the test sequence. As expected, the
three original genes with functionally defined NRSEs (SCG10,
type II sodium channel, and synapsin I; refs. 18-20) were
among them. To assess the specificity of this data base search,
control searches were performed with five randomly shuffled
versions of the composite NRSE, as well as the composite
NRSE entered backwards. Only two genes with three or fewer
mismatches from their respective test sequences were identi-
Table 1. Genes with NRSE-like sequences
Binding Silencing
Gene Sequence comparison activity* activity* Locationt
Consensust
Neuronal genes
Rat SCG1O
Rat type II sodium channel§
Human synapsin§
Rat BDNF§
Rat NMDA rec. 1
Human nicotinic ACh rec. f325
Chicken ,B4-tubulin
Chicken middle neurofilament
Human glycine rec.
Rat glycine rec.
Rat synaptophysin
Human L1l
Rat atrial natriuretic peptide
Mouse calbindinl
Rat GABA-A rec. 8 subunit
Rat nicotinic ACh rec. a7
Mouse P-Lim
Mouse Hes-3
Human CRF
Human olfactory rec.
Mouse synaptotagmin IV
Mouse AMPA rec.
Rat VGF
Rat proenkephalin
Nonneuronal genes
Rat APRT
Sheep keratin
Mouse skeletal actin
Bovine P450-1l13
Human P450-11/3
Human T-cell rec. ,3
Human myosin light chain
Mouse macrophage protein
Rat troponin T
Rat somatostatin trans. factor
TTCAGCACCACGGACAGCGCC
--------------G--T---
-----A------------A--
---------G-------T---
---------TT------A---
---------T--------AT-
---------G-----------
________-----------T--
--------------G----T-
---------T-A------T--
-C-------GT------A---
----------G--------AA
-----------------ACG-
AG-------G-----------
---------GA----G---GA
AG----G-G-G----C---A-- -
---------G-----------
GG-------------------
---------G-----------
G--------CA----------
---------T-------A--A
--T------G----------T
--------GCT----------
--------AC----G--G---
G--------C-------G---
A------------------G-
GG-----------C-------
---------TA------A-G-
---------TA------AAG-
G------A-CT------A---
C--------CAT-----T---
CC-------T-A-C-------
------C--TA------C---
---------T-------A--A
+
+
+
+
+
+
±
±
+
+
+
+
+
+
+
+
+
+
±
+
+ 5'-Reg
5'-Reg
± 5'-Reg
Intron
+ 5'-UTR
+ 5'-UTR
+ Intron
5'-Reg
+ 5'-UTR
5'-UTR
+ Intron
Intron
3'-UTR
5'-UTR
Intron
5'-UTR
5'-UTR
Coding
Intron
Coding
5'-UTR
5'-Reg
5'-UTR
Intron
Intron
5'-Reg
3'-Reg
Jxn
Jxn
Coding
Coding
Coding
Intron
5'-UTR
All genes with two or fewer mismatches to the composite NRSE used in the data base search are listed. Selected genes with
three or greater mismatches, for which NRSF binding was experimentally determined, are listed as well. The NRSE-like
sequences are compared to the revised consensus NRSE (see also Fig. 3). Deviations shown are derived from comparison to
this revised consensus and not to the composite NRSE used in the original data base search. Rec., Receptor; BDNF,
brain-derived neurotrophic factor; NMDA, N-methyl-D-aspartate; ACh, acetylcholine; GABA, y-aminobutyric acid; CRF,
corticotropin-releasing factor; AMPA, a-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid; VGF, vascular endothelial
growth factor; APRT, adenine phosphoribosyltransferase; trans., transactivating.
*A blank space indicates that the sequence has not been tested for the activity.
tlntragenic location: Coding, Intron, 5'-regulatory region (Reg), 5'- or 3'-untranslated region (UTR), or intron/exon junction
(Jxn).
:New NRSE consensus derived from results of search (not original test composite NRSE).
§Previously tested for binding activity (22).
Ilndependently identified in other studies (24, 25).
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fied from all six control searches. This demonstrates that
NRSE-like sequences are present in the data base much more
frequently than random sequences of identical length and base
composition.
As NRSF was identified as a negative regulator of neuronal
genes, the genes identified by the composite NRSE search
were classified as either neuronal or nonneuronal according to
their expression pattern. Neuronal genes are defined as those
expressed in neurons, with no or limited expression elsewhere.
Nonneuronal genes are defined as those expressed in many cell
types, which may include neurons. If only the genes containing
potential NRSEs with two or fewer mismatches from the
composite are considered, then neuronal genes outnumber non-
neuronal genes by 4:1 (20:5). Notably, no bias toward neuronal
genes was found in any of the control data base searches, even
among genes with greater than two mismatches from the com-
posite test sequence. The bias toward neuronal genes in the search
performed using the composite NRSE is consistent with the
proposed function of NRSF, although the presence of non-
neuronal genes suggests an additional role or roles for this
protein. A listing of the 25 neuronal and nonneuronal genes with
two or fewer mismatches from the composite, as well as selected
genes with a greater number of mismatches that were tested for
NRSF binding (see below), is given in Table 1.
Many Potential NRSEs Can Bind NRSF and Repress Tran-
scription. Which of the NRSEs in Table 1 are likely to regulate
the transcription of their respective genes? To address this
question, we tested 24 of the sequences for their ability to bind
NRSF in vitro. We then examined 13 of these potential NRSEs for
silencing activity in transient transfection assays. From these data,
we are able to (i) refine the NRSE core consensus, thereby
facilitating identification of functional NRSEs by sequence in-
spection; (ii) predict NRSF-mediated repression for 17 additional
genes whose NRSEs were not directly tested by a transfection
assay; and (iii) demonstrate NRSF-mediated repression for
NRSEs from seven new potential NRSF target genes.
Of the 24 sequences tested for NRSF binding activity, 16 were
from neuronal genes and 8 were from nonneuronal genes. The
selection of these potential NRSEs for functional assays was not
unbiased. Most were chosen on the basis of their high degree of
similarity to the composite NRSE, and a few were selected for
their divergence to define the limits of NRSF binding (Table 1).
Double-stranded oligonucleotide probes representing these 24
potential NRSEs were tested for their ability to bind in vitro-
translated human NRSF in an EMSA. A truncated form of the
protein, encoded by kH1, was used in this assay (22) because the
full-length form was found to require nonspecific flanking se-
quences to bind efficiently (data not shown).
Fig. 1A shows that 15 of 16 probes derived from neuronal
genes could bind NRSF in a manner similar to the NRSE
originally defined in SCG1O (arrow). Three of these sequences
(from the type II sodium channel, synapsin I, and BDNF
genes) have previously been shown to bind NRSF (22). Two of
the probes derive from the same gene (glycine receptor
inhibitory subunit) in different species. The one probe that did
not bind NRSF derived from the nicotinic acetylcholine
receptor a7 subunit gene (Fig. 1A, lane 17). Furthermore, the
probe derived from the GABA-A receptor 6 subunit gene
yielded a complex with a different mobility from the control
NRSE (Fig. 1A, lanes 1 and 13), suggesting that this probe
either binds NRSF in a different conformation or with a
different affinity. All of the complexes detected contain
NRSF, as EMSAs performed with these probes on control in
vitro translation reactions yielded no specific complexes (data
not shown). Of the eight probes selected from the nonneuronal
genes, five bound NRSF (Fig. 1B), although the cytochrome
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FIG. 1. (A) Recombinant NRSF recognizes NRSEs in 15 different neuron-specific genes. EMSAs were performed using in vitro-synthesized
human NRSF encoded by the AH1 cDNA (22). The arrow indicates the the specific complex. The probes consisted of radiolabeled double-stranded
oligonucleotides derived from the genes listed above the lanes. (B) Recombinant NRSF recognizes NRSEs in five different nonneuronal genes.
EMSAs were performed as in A. The arrow indicates the specific complex. The labeled probes were derived from the genes listed above the lanes.
See Table 1 for full gene names and NRSE sequences.
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P450-113 probes derive from the same gene in different
species. The results from the EMSAs performed with labeled
probes from each gene were confirmed using each oligonu-
cleotide as an unlabeled competitor against a single, labeled
SCG1O NRSE probe. In addition, these competition EMSAs
were performed using NRSF from HeLa nuclear extracts,
confirming that native as well as recombinant NRSF can bind
these sequences (A.J.P. and C.J.S., unpublished data).
To test their ability to repress transcription, 13 of the
sequences assayed for NRSF binding were placed upstream of
the SCG1O promoter reporter construct, CAT3, which lacks
the endogenous SCG1O NRSE (26), and introduced into
CH31OT1/2 cells. These experiments revealed a parallel be-
tween a sequence's ability to bind NRSF in vitro and its ability
to repress transcription in the transient transfection assay (Fig.
2). Taken with the binding data, the results of this transcrip-
tional repression assay identify five new neuronal genes as
strong candidates for NRSF regulation: [N-methyl-D-aspartate
(NMDA) receptor 1, glycine receptor, nAChR ,32, f34-tubulin,
and synaptophysin]. Independent studies have shown that the
nAChR 132 subunit NRSE is necessary for silencing in non-
neuronal cells, in the context of an 1163-bp upstream regula-
tory region (24). On the other hand, the NRSE from the
y-aminobutyric acid (GABA)-A receptor 8 subunit gene,
which gave a complex of aberrant mobility in the EMSA, only
weakly represses transcription. Our data also indicate that at
least two nonneuronal genes may be regulated by NRSF as well
(keratin and P450-11,). In addition, promoter analyses have
defined functional NRSEs in the rat choline acetyltransferase (P.
Lonnerberg, C.J.S., D.J.A., and C. F. Iba'-nez, unpublished data)
and chicken NgCAM (25) genes. These sequences were not in the
data base when we originally performed the searches, but they
have been identified in subsequent searches (C.J.S. and A.J.P.,
unpublished data).
By comparing the 19 different sequences experimentally
determined to bind NRSF normally, a refined consensus was
derived (Fig. 3), with the most commonly found nucleotide
assigned to each position. Thirteen of these positions were
either invariant or differed from consensus only once among
the 19 sequences (Fig. 3A, uppercase letters), while eight of the
positions were more variable (Fig. 3A, lowercase letters).
These results show that the variable residues are not critical for
NRSF binding. Furthermore, in some instances, NRSF was
shown to tolerate a large number of differences from consen-
sus in these variable residues, as the GABA-A receptor and
human cytochrome P450-1113 NRSEs have four and five
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FIG. 2. Sequences that can bind NRSF are able to mediate
silencing. Oligonucleotides derived from a subset of the neuronal and
nonneuronal genes tested for NRSF binding were inserted upstream
of the SCG1O promotor fusion construct, CAT3, which lacks the
endogenous SCG1O NRSE (26), and transiently transfected into
CH31OT1/2 cells, which contain endogenous NRSF. Choramphenicol
acetyltransferase activity is presented as a percentage the activity of
the non-NRSE containing CAT3 plasmid (no NRSE). Error bars
represent the SEMs of two independent experiments.
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FIG. 3. (A). Consensus NRSE derived from 19 sequences for which
NRSF binding was experimentally determined. Nucleotides in upper-
case letters represent positions that are either invariant, or differed
only twice, among the 19 functional NRSEs. Lowercase letters rep-
resent residues that varied more frequently. Dotted residues are those
most frequently modified in functional NRSEs. (B). Potential dual
action of NRSF in repressing terminal differentiation genes. Dashed
line indicates that the repression of activators is more speculative and
is based on the single example of the NRSE in the P-Lim gene (12).
mismatches, respectively; yet they bound NRSF (Table 1).
While some of these changes may have been compensatory, the
relative indifference of NRSF to variations at these residues
suggests that a "core" NRSE can be defined (NNCAGCAC-
CNNGCACAGNNNC). All sequences with six or more devi-
ations from the consensus (e.g., nicotinic acetylcholine recep-
tor a7 subunit and below) were found not to bind NRSF.
NRSEs Are Preferentially Located in Noncoding Regions
and Are Evolutionarily Conserved. Besides the ability to bind
NRSF and repress transcription, two additional criteria were
used to evaluate whether a potential NRSE was likely to be
functionally relevant in vivo: position in the transcription unit
and evolutionary conservation. Functionally relevant regula-
tory sequences tend to be located in nontranscribed or un-
translated regions or in introns, rather than in coding regions.
Where the information was available, we correlated the posi-
tions of NRSEs in their respective transcription units with their
number of deviations from the consensus NRSE. Among 21
neuronal NRSEs with four or fewer mismatches, 90% were
located in noncoding regions, and of those, 50% were in the
5'-untranslated region; one was in the 3'-untranslated region.
The finding that functional NRSEs in neuronal genes are
preferentially located in 5'-flanking and other noncoding
regions supports the idea that these sequences contribute to
the in vivo regulation of these genes.
Important regulatory sequences also tend to be evolution-
arily conserved. Among eight neuronal genes containing
NRSEs for which sequence data was available in different
species, most showed a high degree of nucleotide sequence
conservation (even between amphibian and mammalian spe-
cies) (Table 2). In the case of the glycine receptor inhibitory
subunit the evolutionary conservation of NRSF-binding ability
(for the rat and human genes) was experimentally verified.
Moreover, the intragenic location of all the NRSEs in Table 2
was conserved as well. For example, a putative NRSE in the
first intron of the corticotrophin-releasing factor was con-
served between Xenopus, rat, sheep and human, with no more
than two deviations from consensus (Table 2). These data
provide additional circumstantial evidence that many of the
putative NRSEs we have identified are likely to be functionally
important in vivo.
Repressor Elements in the Sodium/Potassium ATPase a3
Subunit and Dopamine f-Hydroxylase Genes Are Not NRSEs.
Negative regulatory regions in the Na/K ATPase a3 subunit
and dopamine 13-hydroxylase genes have been previously iden-
tified that appear to restrict expression of these genes to
neurons (27, 28). Within these regions, a sequence with limited
similarity to the NRSE was identified in both genes, and it was
suggested that these sequences were binding sites for NRSF
(27, 28). The Na/K ATPase sequence, however, has eight
deviations from consensus including one deleted position, and
I
--I
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Table 2. Evolutionary conservation of potential NRSEs
Gene Species Sequence comparison
Consensus TTCAGCACCACGGACAGCGCC
Atrial natriuretic peptide Human ------ T------AAGA
Horse --------------C--AAAA
Cow ----------T------AAG-
Mouse ----------A------ACG-
Rat -----------------ACG-
Guinea pig -----------------AAG-
Corticotropin releasing factor Human ---------G-----------
Sheep --------T------------
Rat ---------G---------T-
Xenopus -------------------AA
Skeletal actin Cow GC-----------T-------
Pig CC----------T----C--
Rabbit CC-----------T----C--
Mouse GG-----------C-------
NMDA receptor 1 Human ---------G-----------
Rat ---------T--------AT-
Duck ----------G---G------
Calbindin Human AG-------GA----------
Mouse AG-------G-----------
Chicken G--------G-----------
nAChR 3-2 Human ---------------------
Mouse --------------------T
Rat --------------------T
P450-1 13 Human ----------TA------AAG-
Cow ---------TA-----A-G-
Synapsin I Human ---------G-------T---
Rat --T--T---G-------A---
Mouse ---------G---T---A---
Li Human ----------G--------AA
Rat -C----------------AGA
Glycine R. (IS) Human --------------G----T-
Rat ---------T-A------T--
All of the NRSEs listed in the table have been shown to bind NRSF in at least one species (Table 1),
with the exception of the Corticotropin releasing factor gene. Comparisons were included only if at least
two of the sequences were from species from different phylogenetic orders. Glycine R. (IS), glycine
receptor inhibitory subunit; NMDA, N-methyl-D-aspartate.
the dopamine f3-hydroxylase sequence has nine deviations.
This is well above the four-to-five deviation cutoff in binding
found for the other putative NRSEs. To directly determine
whether these sequences could bind NRSF, oligonucleotide
probes representing the two sequences were tested in an
EMSA with in vitro-synthesized NRSF. Fig. 1A (lanes 18 and
19) shows that these elements do not bind NRSF. Further-
more, these elements were not active in competition assays
with native NRSF and did not repress transcription in transient
transfections assays (data not shown). Thus, these sequences
are unlikely to represent true NRSEs.
DISCUSSION
To further understand the role of NRSF in neuronal differ-
entiation, we have sought to identify additional target genes for
this transcriptional repressor. The large size of the composite
NRSE (19/21 bp specified) permitted us to identify such
targets by a data base search, since the site should be present
at random only once every 2.7 x 1011 bp. By contrast, smaller
binding sites for other transcription factors, such as the 6-bp
E-box recognized by MASH1 (29) and other basic helix-loop-
helix proteins (30), are present on average once every 4 kb, too
frequently to be useful in data base searches. We exploited the
search output in two ways. First, by correlating nucleotide
sequence with in vitro DNA binding and in vivo silencing
assays, we have identified NRSE positions not critical for
NRSF binding and thus further refined the NRSE consensus.
Second, we have identified close to two dozen potential
neuronal target genes for NRSF. The majority of these target
genes encode neuronal terminal differentiation products, sup-
porting the idea that NRSF functions as a direct, coordinate
negative regulator of a battery of "end-state" genes. However,
some neural transcription factors were also identified, suggest-
ing that NRSF may also act indirectly by repressing positive
activators of neuronal genes. Finally, our data suggest that
NRSF may regulate some nonneuronal genes as well.
Defining an NRSE. The results of our functional assays
indicated that at least 7 of the 21 residues of the NRSE are not
critical for NRSF binding. This leaves a 14-bp core sequence that
is likely to contain residues that are relatively more important for
function. Defining a core sequence facilitates identification of
potential NRSEs by visual sequence inspection, by placing a
greater weight on deviations from the core sequence rather than
by simply counting the total number of mismatches.
In principle, residues essential for NRSF binding could be
identified by systematic mutational analysis of NRSEs. Previ-
ously, we demonstrated that mutating two adjacent G residues
(positions 12 and 13) to T residues drastically reduced both
binding and silencing (18). However, the rat glycine receptor
inhibitory subunit NRSE has anA at position 13 (as well as two
other deviations) and can bind NRSF much better than the
double mutant. In fact, a comparison of the different naturally
occurring, functional NRSEs taken together with its relatively
large size, suggests that no single residue is critical for binding.
This implies that a single point mutational study would be
largely uninformative. These results are also consistent with
the idea that the eight zinc finger DNA-binding domain of
Neurobiology: Schoenheff et aL
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NRSF may make multiple contacts along the NRSE (31, 32).
However, certain residues may be more important than others,
as only two of the five potential NRSEs with five deviations
were able to bind NRSF (Table 1).
Role ofNRSEs in Nonneuronal Genes. Our data support the
idea that the primary function ofNRSF is to regulate neuronal
gene expression. Nevertheless, we identified five nonneuronal
genes with functional NRSEs. In the case of the skeletal actin
and cytochrome P450-11(3 genes, moreover, the NRSE is
highly conserved in both sequence and intragenic location
across species (Table 2), implying that it may be functionally
important in vivo.
What does the presence of NRSEs in non-neuronal genes
say about the potential function of NRSF? It is possible that
NRSF could function to repress nonneuronal as well as
neuronal genes in certain tissues. Alternatively, NRSF could
activate transcription of some of these nonneuronal genes;
other transcription factors can act as either activators or
repressors (33-35). Finally, it is formally possible that other
binding factors exist that interact with the NRSEs present in
nonneuronal genes.
The case of the skeletal muscle actin gene is particularly
informative, as this gene is expressed in a cell type (muscle) in
which NRSF is known to be expressed and to repress at least
one neuronal gene, the NaII channel (19, 21, 36). The repres-
sive function of NRSF on the actin gene in muscle cells might
be overridden by strong, muscle-specific activators that inter-
act with the actin but not the NaIl channel gene; alternatively,
NRSF could even function as an activator of the actin gene in
a muscle cell context. Irrespective of its role in muscle, NRSF
could still function to repress the skeletal actin gene in
nonmuscle cells. Whatever the case, the skeletal actin gene
data imply that NRSF may not necessarily be the primary
determinant of the transcriptional state of every NRSE-
containing gene.
Function of NRSF in the Nervous System. The neuronal
genes identified by the NRSE data base search encode proteins
that contribute to many different aspects of the neuronal
phenotype: neurotransmitter receptors, ion channels, neuro-
transmitter-synthesizing enzymes, neuropeptides, cell adhe-
sion molecules, synaptic vesicle proteins, and cytoskeletal com-
ponents. This suggests that NRSF-regulated genes are involved in
most or all neuron-specific functions. Importantly, some NRSE-
containing genes are only expressed in a subset of neurons,
indicating that NRSF regulation is not limited to "panneuronal"
genes. NRSF may function in nonneuronal tissues to prevent
ectopic expression of these genes and/or in neuronal precursors
to prevent the premature activation of these genes.
The identification of the neuronal transcription factor-
encoding gene, P-Lim, which contains a sequence identical to
a functional NRSE (Table 1), raises the possibility that NRSF
may repress neuronal gene expression by a dual mechanism
(Fig. 3B). P-Lim is a LIM homeodomain protein that is a
known activator of pituitary-specific genes (12). In addition to
its expression in developing and adult pituitary neuroendo-
crine cells (12, 37), P-Lim is also transiently expressed by motor
neuron precursors (11). P-Lim interacts with another tran-
scription factor, Pit-1, a POU-domain protein required for
pituitary development (12). These facts suggest that relief from
NRSF-imposed repression could allow expression of positively
acting transcriptional regulators, which in turn activate tran-
scription of terminal differentiation genes (Fig. 3B). Thus,
NRSF may act indirectly as well as directly to repress the
neuronal differentiation program.
Note Added in Proof. The m4 muscarinic acetylcholine receptor gene
has recently been shown to contain a functional NRSE (38).
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